208 related articles for article (PubMed ID: 23494578)
21. Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.
Sasabe N; Keyamura Y; Obama T; Inoue N; Masuko Y; Igarashi Y; Aiuchi T; Kato R; Yamaguchi T; Kuwata H; Iwamoto S; Miyazaki A; Hara S; Yoshikawa T; Itabe H
Lipids Health Dis; 2014 Mar; 13():48. PubMed ID: 24625108
[TBL] [Abstract][Full Text] [Related]
22. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors.
Bowry VW; Stanley KK; Stocker R
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10316-20. PubMed ID: 1332045
[TBL] [Abstract][Full Text] [Related]
23. Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.
Musliner TA; Long MD; Forte TM; Nichols AV; Gong EL; Blanche PJ; Krauss RM
J Lipid Res; 1991 Jun; 32(6):917-33. PubMed ID: 1940624
[TBL] [Abstract][Full Text] [Related]
24. Selective uptake from LDL is stimulated by unsaturated fatty acids and modulated by cholesterol content in the plasma membrane: role of plasma membrane composition in regulating non-SR-BI-mediated selective lipid transfer.
Seo T; Velez-Carrasco W; Qi K; Hall M; Worgall TS; Johnson RA; Deckelbaum RJ
Biochemistry; 2002 Jun; 41(25):7885-94. PubMed ID: 12069577
[TBL] [Abstract][Full Text] [Related]
25. Investigation of Lipoproteins Oxidation Mechanisms by the Analysis of Lipid Hydroperoxide Isomers.
Kato S; Osuka Y; Khalifa S; Obama T; Itabe H; Nakagawa K
Antioxidants (Basel); 2021 Oct; 10(10):. PubMed ID: 34679733
[TBL] [Abstract][Full Text] [Related]
26. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ
J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525
[TBL] [Abstract][Full Text] [Related]
28. Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol.
Garner B; Witting PK; Waldeck AR; Christison JK; Raftery M; Stocker R
J Biol Chem; 1998 Mar; 273(11):6080-7. PubMed ID: 9497325
[TBL] [Abstract][Full Text] [Related]
29. HDL capacity to inhibit LDL oxidation in well-trained triathletes.
Brites F; Zago V; Verona J; Muzzio ML; Wikinski R; Schreier L
Life Sci; 2006 May; 78(26):3074-81. PubMed ID: 16488445
[TBL] [Abstract][Full Text] [Related]
30. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
Moradi H; Pahl MV; Elahimehr R; Vaziri ND
Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
[TBL] [Abstract][Full Text] [Related]
31. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase.
Itabe H; Hosoya R; Karasawa K; Jimi S; Saku K; Takebayashi S; Imanaka T; Takano T
J Biochem; 1999 Jul; 126(1):153-61. PubMed ID: 10393333
[TBL] [Abstract][Full Text] [Related]
32. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.
Kontush A; Chantepie S; Chapman MJ
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1881-8. PubMed ID: 12920049
[TBL] [Abstract][Full Text] [Related]
33. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
[TBL] [Abstract][Full Text] [Related]
34. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I.
Panzenböck U; Kritharides L; Raftery M; Rye KA; Stocker R
J Biol Chem; 2000 Jun; 275(26):19536-44. PubMed ID: 10751387
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of HepG2 cell-derived apolipoprotein A-I-containing lipoproteins on cholesteryl ester accumulation in macrophages.
Kawano T; Hakamata H; Ohta T; Ding Y; Yoshida M; Ueda S; Horiuchi S
Biochemistry; 1997 Aug; 36(32):9816-25. PubMed ID: 9245414
[TBL] [Abstract][Full Text] [Related]
36. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
Hedrick CC; Hassan K; Hough GP; Yoo JH; Simzar S; Quinto CR; Kim SM; Dooley A; Langi S; Hama SY; Navab M; Witztum JL; Fogelman AM
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1946-52. PubMed ID: 10938016
[TBL] [Abstract][Full Text] [Related]
37. Formation of new HDL particles from lipid-free apolipoprotein A-I.
Clay MA; Barter PJ
J Lipid Res; 1996 Aug; 37(8):1722-32. PubMed ID: 8864956
[TBL] [Abstract][Full Text] [Related]
38. Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein.
Sato M; Ohkawa R; Yoshimoto A; Yano K; Ichimura N; Nishimori M; Okubo S; Yatomi Y; Tozuka M
Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27422844
[TBL] [Abstract][Full Text] [Related]
39. Lipoprotein associated phospholipase A2 inhibition reduces generation of oxidized fatty acids: Lp-LPA2 reduces oxidized fatty acids.
Rosenson RS; Vracar-Grabar M; Helenowski I
Cardiovasc Drugs Ther; 2008 Feb; 22(1):55-8. PubMed ID: 18214661
[TBL] [Abstract][Full Text] [Related]
40. Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltransferase activity.
Bielicki JK; Forte TM
J Lipid Res; 1999 May; 40(5):948-54. PubMed ID: 10224164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
